HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Anthony Daniyan Selected Research

Wilms Tumor (Wilm's Tumor)

2/2024A dual-receptor T-cell platform with Ab-TCR and costimulatory receptor achieves specificity and potency against AML.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Anthony Daniyan Research Topics

Disease

4Neoplasms (Cancer)
02/2024 - 08/2020
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
02/2024 - 12/2021
2Neutropenia
12/2020 - 08/2020
2COVID-19
12/2020 - 08/2020
1Wilms Tumor (Wilm's Tumor)
02/2024
1Hematologic Neoplasms (Hematological Malignancy)
02/2024
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
12/2021
1Infections
08/2020
1Respiratory Insufficiency (Respiratory Failure)
08/2020
1Asthma (Bronchial Asthma)
03/2006

Drug/Important Bio-Agent (IBA)

2Chimeric Antigen ReceptorsIBA
02/2024 - 12/2020
2Oxygen (Dioxygen)IBA
12/2020 - 08/2020
1WT1 ProteinsIBA
02/2024
1AntigensIBA
02/2024
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
02/2024
1venetoclaxIBA
12/2021
1Antiviral Agents (Antivirals)IBA
12/2020
1ANC 1IBA
08/2020
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
08/2020
1Filgrastim (Neupogen)FDA Link
08/2020
1bifenthrinIBA
03/2006

Therapy/Procedure

3Therapeutics
02/2024 - 12/2020
1Salvage Therapy
12/2021
1Cell Transplantation
12/2020